Coloplast AS
- BID
55.3
- ASK
55.32
- 1,175 Units1,175 Units
- 07/21, 16:36:59 PM
Sector and Industry
Healthcare, Healthcare Equipment
Performance (1Y)
31.43%
Market Cap
11.53 Bil.
P/E Ratio
33.66
Dividend Yield
4.24 %
Earnings per Share
2.17 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Abbott Laboratories | 185.26 Bil. | 39.29 Bil. | 33.69 | -53.32 % | 0.00 | - |
| Intuitive Surgical Inc | 171.24 Bil. | 8.92 Bil. | 71.93 | +17.90 % | 0.00 | - |
| Boston Scientific Corp | 120.40 Bil. | 17.79 Bil. | 49.17 | +49.88 % | 0.00 | - |
| Stryker Corp. | 114.47 Bil. | 22.26 Bil. | 41.85 | +3.99 % | 0.00 | - |
| Medtronic PLC | 90.93 Bil. | 31.27 Bil. | 22.35 | -4.61 % | 0.00 | - |
| Siemens Healthineers AG | 51.40 Bil. | 23.38 Bil. | 24.04 | +10.40 % | 0.00 | - |
| Hoya Corp | 48.59 Bil. | 5.43 Bil. | 35.69 | +17.33 % | 0.00 | - |
| Becton Dickinson and Co. | 45.46 Bil. | 19.79 Bil. | 32.18 | -3.33 % | 0.00 | - |
| Edwards Lifesciences Corp | 42.15 Bil. | 5.38 Bil. | 47.11 | -27.44 % | 0.00 | - |
| Alcon AG | 33.20 Bil. | 9.24 Bil. | 38.41 | -7.56 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 55.32 G | 0 Units |
| PRICE DETERMINATION TIME | 07/21/2026 / 04:34:05 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 55.94 | 54.78 |
| PREV. DAY'S PRICE | 55.6 | (07/20) |
| CHANGE DAY BEFORE | -0.28 | -0.50 % |
| 52 WEEK HIGH / LOW | 84.96 (09/10) | 49.48 (06/18) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026e | 2027e | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | 2.99 | 3.01 | 2.17 | 3.33 | 3.57 |
DIVIDENDS PER SHARE | 2.82 | 2.95 | 3.09 | 2.67 | 2.98 |
DIVIDEND YIELD IN % | 2.81 % | 2.51 % | 4.24 % | - | - |
DIVIDEND GROWTH IN % | 4.74 % | 4.49 % | 4.71 % | - | - |
PRICE - EARNINGS RATIO | 33.67 | 38.95 | 33.66 | 16.97 | 15.85 |
PRICE - BOOK RATIO | 9.71 | 10.99 | 7.59 | - | - |
PRICE - SALES RATIO | 6.58 | 7.28 | 4.39 | - | - |
PRICE - CASH FLOW RATIO | 38.12 | 71.15 | 18.42 | - | - |
Master Data
| WKN | A1KAGC |
| ISIN | DK0060448595 |
| SYMBOL | CBHD |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | Coloplast |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | Danish Krone |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Healthcare Equipment |
| NUMBER OF SHARES | 207.37 Mil. |
| MARKET CAPITALISATION | 11.53 Bil. |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | 2.36 % | 10.41 % | -5.54 % | -22.26 % | -31.43 % | -49.01 % | -61.96 % | -23.73 % |
| HIGH | 57.02 | 57.02 | 59.04 | 74.36 | 84.96 | 130.55 | 160.00 | 78.02 |
| LOW | 53.02 | 49.58 | 49.48 | 49.48 | 49.48 | 49.48 | 49.48 | 49.48 |
Dividende
pro Aktie
Company profile
Coloplast A/S engages in the developing, manufacture, and markets medical products. It operates through the following segments: Chronic Care, Voice and Respiratory Care, Interventional Urology, Advanced Wound Dressings, and Biologics. The Chronic Care segment covers the sale of ostomy care products and continence care products. The Voice and Respiratory Care segment refers to the sale of laryngectomy and tracheostomy products. The Interventional Urology segment includes the sale of urological products, including disposable products. The Advanced Wound Dressings segment focuses on the sale of wound and skin care products. The Biologics segment represents a new segment covering the sale of tissue-based products. The company was founded by Aage Louis-Hansen and Johanne Louise-Hansen in 1954 and is headquartered in Humlebaek, Denmark.
Structured products for Coloplast AS
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.